Please assess the completion status of the following clinical trial:

Trial Title: Effect of Nebulized Bronchodilators on Heart Rate

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults who required inhaled bronchodilator therapy in the form of short acting beta adrenergic receptor agonist and short acting anti-cholinergic treatment every 4-6 hours for respiratory functions~Exclusion Criteria:~* Known allergy or sensitivity to study medications~* Baseline heart rate was greater than 110 beats per minute

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Levalbuterol 0.63 (Type: ACTIVE_COMPARATOR): Patients received an initial dose of levalbuterol 0.63 mg alternating with albuterol 2.5 mg.
- Levalbuterol 1.25 (Type: ACTIVE_COMPARATOR): Patients received an initial dose of levalbuterol 1.25 mg alternating with albuterol 2.5 mg.

Based on this trial design, predict the completion outcome and termination type (if applicable).